
Nephrologist

No OPD information available
Islet Cell Transplantation
Kidney Transplant
Pancreas Transplant
Type 1 Diabetes (T1D)
Acute Tubular Necrosis
Autonomic Neuropathy
Cerebral Hypoxia
Chronic Kidney Disease
Heart Transplant
Hypertension
Philip J. O'Connell is a male doctor who helps people with different health problems like diabetes, kidney issues, and heart conditions. He is skilled in Islet Cell Transplantation, Kidney Transplant, and Pancreas Transplant. He also treats Type 1 Diabetes, Acute Tubular Necrosis, Autonomic Neuropathy, Cerebral Hypoxia, Chronic Kidney Disease, and Hypertension.
Dr. O'Connell takes care of patients by using special treatments and skills to make them feel better. He talks to patients in a kind and clear way, which helps them trust him. Patients like him because he listens to their concerns and explains things well.
Dr. O'Connell stays updated with the latest medical knowledge and research to provide the best care for his patients. He reads medical journals and attends conferences to learn new things. This helps him give the most effective treatments to his patients.
Dr. O'Connell works well with other doctors and medical professionals. He shares his knowledge and collaborates with colleagues to give the best care possible. His teamwork approach helps patients get comprehensive treatment.
Dr. O'Connell's work has positively impacted many patients' lives. He has helped people with kidney transplants live healthier lives. His research on kidney transplant failure in African American recipients has been published in a prestigious medical journal. He has also been involved in clinical trials to improve treatments for kidney transplant recipients.
In summary, Philip J. O'Connell is a caring and skilled doctor who uses the latest medical knowledge to help patients with various health issues. His work has made a positive impact on many people's lives, especially those with kidney problems.
Enrollment Status: Terminated
Published: April 24, 2024
Intervention Type: Drug, Biological
Study Drug:
Study Phase: Phase 3
